Drawing for VULNERABILITY NETWORK

USPTO serial 97472735

VULNERABILITY NETWORK

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
GILBERT, HANNAH B
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with VULNERABILITY NETWORK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen Won

Karen Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.One Financial CenterBoston, MA 02111United States

Goods and services

ClassDescriptionStatusFirst use
042Scientific research consulting services in the field of medicine, genetics, oncology, biology, biotechnology and pharmaceuticals; scientific research services, namely, analysis of scientific and clinical data in the fields of genetic, biologic, and oncologic data; scientific research consulting in the fields of healthcare, medicine, genetics, oncology, biology, and pharmaceuticals; genetic mapping for scientific and medical purposes; providing medical and scientific research information in the fields of genetics, oncology, biology, and pharmaceuticals; drug discovery services; providing scientific, medical, and clinical research and scientific consulting services in the fields of genetics, oncology, biology, and pharmaceuticals by using machine learning technology, artificial intelligence technology, and biotechnology methods; medical and scientific research and scientific consulting, namely, designing and supporting clinical trials for others; scientific research and development services in the collection of information and data on biologicals for research purposes; providing on-line searchable genetic reference databases being collections of gene sequences for scientific research purposes; scientific research services, namely, disease modeling for research purposes; scientific analysis services using machine-learning algorithms for analysis of bioinformatics data in the field of research and development of therapeutic biomolecules for the treatment of cancer and other diseases; scientific research in the field of biomarker rankings; scientific research and development of pharmaceutical preparations and medicines; pharmaceutical drug development services; consulting services in the field of pharmaceutical research and development; medical and scientific research in the field of cancer treatment and diagnosisACTIVE—
044Consulting services in the field of healthcare; medical analysis services of healthcare, medical, genetic, scientific, biologic, clinical and oncologic data relating to the treatment of persons; healthcare and medical services, namely, providing databases in the fields of genetic, oncological, and biological information for inputting, collecting, analyzing and managing scientific data for treatment and diagnostic purposes; healthcare services, namely, medical services in the nature of analyzing scientific genetic, oncological, and biological data for treatment and diagnostic purposes by using machine learning and artificial intelligence technologies; providing clinical medical consulting services in the fields of genetics, oncology, biology, and pharmaceuticals by using machine learning technology, artificial intelligence technology, and biotechnology methodsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 18, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 18, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 13, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 20, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 19, 2026EXT5SOU EXTENSION 5 FILED—
Nov 19, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 18, 2025EX4GSOU EXTENSION 4 GRANTED—
Nov 18, 2025EXT4SOU EXTENSION 4 FILED—
Nov 18, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 8, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 8, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 8, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 8, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 8, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 27, 2025EX3GSOU EXTENSION 3 GRANTED—
May 27, 2025EXT3SOU EXTENSION 3 FILED—
May 27, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 2, 2024EX2GSOU EXTENSION 2 GRANTED—
Dec 2, 2024EXT2SOU EXTENSION 2 FILED—
Dec 2, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 31, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 30, 2024EX1GSOU EXTENSION 1 GRANTED—
May 30, 2024EXT1SOU EXTENSION 1 FILED—
May 30, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 22, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 22, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 22, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 22, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 12, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 17, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 27, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 13, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 13, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 13, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 13, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 29, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 29, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 29, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 13, 2023DOCKASSIGNED TO EXAMINER—
May 11, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 11, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 11, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 6, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 6, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 6, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2023DOCKASSIGNED TO EXAMINER—
Jul 12, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 27, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance